Published Articles

Published Articles

2020

JUNE 1, 2020 – Good Manufacturing Practices: Challenges with Compliance

MARCH 19, 2020 – Pharma Almanac “Round Table”

MARCH 10, 2020 – Improving Bioavailability & Solubility

MARCH 6, 2020 – Women in Pharma: Reimagining the Glass Ceiling

MARCH 6, 2020 – The Year That Was and the Year That Will Be

MARCH 1, 2020 – Seeking Early Answers to Formulation Questions

JANUARY 24, 2020 – Optimizing Ophthalmic Drug Delivery for Therapeutic Effectiveness


2019

DECEMBER 2, 2019 – Nanomilling: Shaping the Solubility and Bioavailability of Today’s Therapeutics

NOVEMBER 6, 2019 – Overcoming the Challenges in Drug-Device Combination Product Formulation

NOVEMBER 6, 2019 – The Demands of the Perfect Dose

SEPTEMBER 29, 2019 – Women’s Equality Day: Pharma is Leveling the Playing Field

SEPTEMBER 1, 2019 – Combination Products for Medical Device Developers

AUGUST 29, 2019 – Overcoming Complexity – Trends Shaping The Drug Formulation Industry

JUNE 18, 2019 – Looking Beyond the Solubility Horizon

JUNE 15, 2019 – The Big Freeze: Obtaining the Best Results from Lyophilization

JUNE 13, 2019 – Outsourcing Formulation Development & Manufacturing: CDMOs Shift to Offer More Specialized Services

APRIL 29, 2019 – Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential

APRIL 29, 2019 – Patient-Centric Drug Development Comes of Age

APRIL 20, 2019 – Ask the Expert: Analytical Method Validation

MARCH 16, 2019 – Particle Sciences’ Barbara Morgan on Pharma and Diversity

MARCH 11, 2019 – Improving Bioavailability & Solubility: Chemical & Physical Modification vs. Formulation Development


2018

DECEMBER 11, 2018 – Dissolving Solubility Challenges

NOVEMBER 19, 2018 – Early-Stage Formulation Considerations

SEPTEMBER 29, 2018 – American Pharma Review – An Overview of the Zeta Potential – Part 1: The Concept


2016

APRIL 10, 2016 – Particle Sciences — Targeted Drug Products Using Nano Formulations

MARCH 29, 2016 – Particle Sciences — An API’s Characteristics Determine the Best Approach to Improving Solubility


2015

JANUARY 29, 2015 – Particle Sciences Positions Itself as a Bioavailability Tool for Most Drug Forms


2014

SEPTEMBER 9, 2014 – Vaccine Technologies & the Rationale for New Nanoparticle Formulations


2013

NOVEMBER 19, 2013 – Particle Sciences is Highlighted in the CHAARM Newsletter 2013

SEPTEMBER 29, 2013 – The Central Role Of Analytic Method Development And Validation In Pharmaceutical Development


2012

DECEMBER 12, 2012 – Observations on Nanotechnology-based Drug Delivery Approaches: Translating Nanotechnology from Bench to Pharmaceutical Market

AUGUST 29, 2012 – Comments On Biopharmaceutical Classification System And Formulation Development

MARCH 11, 2012 – Solid Dosage Forms – Polymers for Solid Oral Dosage Forms

JANUARY 29, 2012 – Bioavailability Enhancement: A Novel Spray-Drying Technology to Improve the Bioavailability of Biopharmaceutical Classification System Class II Molecules


2011

SEPTEMBER 20, 2011 – The Zeta Potential & its Use in Pharmaceutical Applications – Part 2: Measurement Techniques & Uses

AUGUST 11, 2011 – Charged Interfaces in Polar & Non-Polar Media & the Concept of the Zeta Potential

MAY 22, 2011 – Particle Sciences & Horiba Instruments: Providing Clients a Total Solution


2010

NOVEMBER 29, 2010 – Microbicides: A promising strategy to reduce HIV infection

OCTOBER 29, 2010 – The relentless effort to curtail the HIV pandemic continues as researchers aggressively investigate alternative prevention tools

SEPTEMBER 7, 2010 – Update from CHAARM, a Particle Sciences Client

AUGUST 29, 2010 – Particle Sciences: Providing Formulation & Analytic Services to Meet Demanding Drug Delivery Challenges

JULY 2, 2010 – Selection of Active Pharmaceutical Ingredients (APIs) and Excipients for Topical Formulations

JUNE 14, 2010 – Forced Degradation as an Integral Part of HPLC Stability-Indicating Method Development


2009

SEPTEMBER 23, 2009 – Solid Lipid Nanoparticles: Drug Delivery Technology September 2009 Vol 9 No 8. Solid Lipid Nanoparticles for the Delivery of Pharmaceutical Actives.

MARCH 29, 2009 – The Issues & Challenges Involved in In Vitro Release Testing for Semi-Solid Formulations


2007

DECEMBER 29, 2007 – Particle Size Distribution: Light Microscopic Determination of Particle Size Distribution in an Aqueous Gel.

OCTOBER 31, 2007 – Identification Of Human Natriuretic Hormone Cain Et Al PNAS October 31, 2007

APRIL 28, 2007 – Microcapsules With Liquid Cores And Polymer Shells Made By Solvent Evaporation

FEBRUARY 28, 2007 – Microencapsulated Non-aqueous Dispersions


2006

OCTOBER 28, 2006 – pH-sensitive Microgels

OCTOBER 28, 2006 – Manufacture Of Microspheres As Carrier Particles For Active Biomolecules

JUNE 8, 2006 – Targeted Delivery Of Actives: Cationic Nanoparticles For Use In Hair And Skin Products

APRIL 29, 2006 – Dry Eye Syndrome: A Review & Novel Formulation Approach

APRIL 28, 2006 – Nebulizable Nanoparticle Dispersions: A Novel Inhalable Dosage Form

APRIL 8, 2006 – A Review Of Sunscreen Safety And Efficacy


2005

MAY 7, 2005 – Microbicides For HIV AIDS Electrophoretic Fingerprinting The H9 Cell Model System

JANUARY 17, 2005 – Phase III Modeling AIDS 06


2004

DECEMBER 28, 2004
TMC120 Blocks HIV-1 Infection In Cellular And Human Cervical Tissue Models

JUNE 28, 2004 – Regulatory Challenges In Microbicide Development